Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSms pharmaceuticals

    Sms Pharmaceuticals

    Jump to
    • SMS Pharma Standalone September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y

      SMS Pharma Standalone September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y

    • Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL, Power Grid, Dr Agarwal's Eye Hospital in focus on 28 August

      Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL, Power Grid, Dr Agarwal's Eye Hospital in focus on 28 August

      Stocks to Watch, 28 August: Stocks like Sri Lotus Developers, InterGlobe Aviation, SMS Pharmaceuticals, E2E Networks, Mangal Electrical Industries, HFCL, Power Grid Corporation of India, Edelweiss Financial Services, and Dr Agarwal's Eye Hospital will be in focus on August 28.

    • SMS Pharma Standalone June 2025 Net Sales at Rs 196.05 crore, up 19.21% Y-o-Y

      SMS Pharma Standalone June 2025 Net Sales at Rs 196.05 crore, up 19.21% Y-o-Y

    • Trade Spotlight: How should you trade Sumitomo Chemical, Prestige Estates, Kalyan Jewellers, Sharda Cropchem, Godfrey Phillips and others on July 21?

      Trade Spotlight: How should you trade Sumitomo Chemical, Prestige Estates, Kalyan Jewellers, Sharda Cropchem, Godfrey Phillips and others on July 21?

      The consolidation is expected to continue until the Nifty 50 delivers a strong close above the midline of the Bollinger Bands. Below are some short-term trading ideas to consider.

    • SMS Pharmaceuticals shares surge 6% on 'Zero' observations from USFDA

      SMS Pharmaceuticals shares surge 6% on 'Zero' observations from USFDA

      SMS Pharmaceuticals Share Price | USFDA has conducted the inspection from June 23-25, 2025, which concluded with zero Form 483 observation.

    • Stocks to Watch Today: Mobikwik, Western Carriers, PB Fintech, Texmaco Rail, Om Infra, JSW Energy, SMS Pharmaceuticals in focus on 26 June

      Stocks to Watch Today: Mobikwik, Western Carriers, PB Fintech, Texmaco Rail, Om Infra, JSW Energy, SMS Pharmaceuticals in focus on 26 June

      Stocks to Watch, 26 June: Stocks like One Mobikwik Systems, Western Carriers India, PB Fintech, Texmaco Rail and Engineering, Om Infra, JSW Energy, and SMS Pharmaceuticals will be in focus on June 26.

    • SMS Pharma Standalone March 2025 Net Sales at Rs 248.20 crore, up 0.98% Y-o-Y

      SMS Pharma Standalone March 2025 Net Sales at Rs 248.20 crore, up 0.98% Y-o-Y

    • SMS Pharma Consolidated March 2025 Net Sales at Rs 248.20 crore, up 0.98% Y-o-Y

      SMS Pharma Consolidated March 2025 Net Sales at Rs 248.20 crore, up 0.98% Y-o-Y

    • SMS Pharma Consolidated December 2024 Net Sales at Rs 173.35 crore, up 7.35% Y-o-Y

      SMS Pharma Consolidated December 2024 Net Sales at Rs 173.35 crore, up 7.35% Y-o-Y

    • SMS Pharma Standalone December 2024 Net Sales at Rs 173.35 crore, up 7.35% Y-o-Y

      SMS Pharma Standalone December 2024 Net Sales at Rs 173.35 crore, up 7.35% Y-o-Y

    • SMS Pharma Consolidated September 2024 Net Sales at Rs 196.75 crore, up 18.07% Y-o-Y

      SMS Pharma Consolidated September 2024 Net Sales at Rs 196.75 crore, up 18.07% Y-o-Y

    • Stock Radar: Eicher Motors, Hero MotoCorp, Mankind Pharma, Ashoka Buildcon, KRN Heat, ITC in focus on Thursday

      Stock Radar: Eicher Motors, Hero MotoCorp, Mankind Pharma, Ashoka Buildcon, KRN Heat, ITC in focus on Thursday

      Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, Syngene International, Coal India, and Aurobindo Pharma will also be in focus on October 3.

    • SMS Pharma Consolidated June 2024 Net Sales at Rs 164.45 crore, up 21.51% Y-o-Y

      SMS Pharma Consolidated June 2024 Net Sales at Rs 164.45 crore, up 21.51% Y-o-Y

    • SMS Pharma Standalone June 2024 Net Sales at Rs 164.45 crore, up 21.51% Y-o-Y

      SMS Pharma Standalone June 2024 Net Sales at Rs 164.45 crore, up 21.51% Y-o-Y

    • SMS Pharma Consolidated March 2024 Net Sales at Rs 245.80 crore, up 64.5% Y-o-Y

      SMS Pharma Consolidated March 2024 Net Sales at Rs 245.80 crore, up 64.5% Y-o-Y

    • SMS Pharma Standalone March 2024 Net Sales at Rs 245.80 crore, up 64.5% Y-o-Y

      SMS Pharma Standalone March 2024 Net Sales at Rs 245.80 crore, up 64.5% Y-o-Y

    • Bulk deals: Quant MF buys Rs 183 cr stake in Apeejay Surrendra Park Hotels

      Bulk deals: Quant MF buys Rs 183 cr stake in Apeejay Surrendra Park Hotels

      Quant Small Cap Fund picked up 93,20,000 shares or a 4.37 percent stake at an average price of Rs 196.33

    • SMS Pharma Consolidated December 2023 Net Sales at Rs 161.48 crore, up 8.52% Y-o-Y

      SMS Pharma Consolidated December 2023 Net Sales at Rs 161.48 crore, up 8.52% Y-o-Y

    • SMS Pharma Standalone December 2023 Net Sales at Rs 161.48 crore, up 8.52% Y-o-Y

      SMS Pharma Standalone December 2023 Net Sales at Rs 161.48 crore, up 8.52% Y-o-Y

    • SMS Pharma Consolidated September 2023 Net Sales at Rs 166.64 crore, up 4.52% Y-o-Y

      SMS Pharma Consolidated September 2023 Net Sales at Rs 166.64 crore, up 4.52% Y-o-Y

    • SMS Pharma Consolidated June 2023 Net Sales at Rs 135.34 crore, up 110.19% Y-o-Y

      SMS Pharma Consolidated June 2023 Net Sales at Rs 135.34 crore, up 110.19% Y-o-Y

    • SMS Pharma Standalone June 2023 Net Sales at Rs 135.34 crore, up 110.19% Y-o-Y

      SMS Pharma Standalone June 2023 Net Sales at Rs 135.34 crore, up 110.19% Y-o-Y

    • SMS Pharma Consolidated March 2023 Net Sales at Rs 149.43 crore, up 145.29% Y-o-Y

      SMS Pharma Consolidated March 2023 Net Sales at Rs 149.43 crore, up 145.29% Y-o-Y

    • SMS Pharma Standalone March 2023 Net Sales at Rs 149.43 crore, up 145.29% Y-o-Y

      SMS Pharma Standalone March 2023 Net Sales at Rs 149.43 crore, up 145.29% Y-o-Y

    • SMS Pharma Standalone December 2022 Net Sales at Rs 148.80 crore, up 22.72% Y-o-Y

      SMS Pharma Standalone December 2022 Net Sales at Rs 148.80 crore, up 22.72% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347